BMY vs PSX · P/E 17, rev $24.46B vs P/E 17, rev $83.54B
Bristol-Myers Squibb Company (BMY) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the BMY and PSX stock pages for the full models.
Not investment advice.